Home » Topics » BioWorld Science, Patents

BioWorld Science, Patents
RSS

Sumitomo claims psychotropic lactam derivatives

July 5, 1996

5-HT2 ligands claimed by Janssen

July 5, 1996

Anxiolytic/antidepressant 5-HT1A receptor ligands from AHP

July 5, 1996

Lilly discloses antiobesity proteins

July 5, 1996

NPY1 ligands claimed by Pfizer

July 5, 1996

HHS scientist discovers cartilage formation stimulant

July 5, 1996

Kyowa Hakko isolates antitumor/antibacterial compound from Streptomyces

July 5, 1996

Johns Hopkins researches HIC-1-associated tumor

July 5, 1996

Zeneca reveals antiproliferative aniline derivatives

July 5, 1996

Halistatin 3: Antineoplastic agent of marine origin

July 5, 1996

Popular Stories

Today's news in brief
BioWorld
BioWorld briefs for Dec. 9, 2025.
Medline plans record-setting $5.37B IPO
BioWorld MedTech
Almost a year since first filing its S-1 to return to public markets, Medline Inc. revealed the price range for the most awaited IPO of 2025. The massive medical...
Today's news in brief
BioWorld MedTech
BioWorld MedTech briefs for Dec. 9, 2025.
ASH 2025: Tec-dara shines on ‘functional cure’ Majestec-3 MM data
BioWorld
Impressive results of a potential second-line combination treatment for multiple myeloma from the Majestec-3 trial of teclistamab plus daratumumab raised eyebrows...
Epigenetic technology could eliminate misfolded prion proteins
BioWorld Science
The number of deaths caused by prion diseases reaches about 30,000 annually. Only 5 months pass from the diagnosis of seemingly healthy patients to the fatal...